Healthcare Reports

Global Systemic Lupus Erythematosus Market Size, Trends & Analysis - Forecasts to 2026 By Drug Class (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Immunosuppressants, Corticosteroids, Disease-Modifying Anti-Rheumatic Drugs, BLyS-specific Inhibitors or Monoclonal Antibodies, Anticoagulants, Biologics, Others), By Route of Administration (Oral, Intravenous, Subcutaneous), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The systemic lupus erythematosus market is estimated to be valued at USD 3.30 Billion in 2021 and is projected to reach USD 4.67 Billion by 2026 at a CAGR of 7.2%. The core drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, the growing need for targeted treatment, soaring levels of inflammatory diseases, increasing therapeutic interventions, and the emergence of biologics. Read More »


July 21 : 2021

Global Pediatric Oxygen Concentrator Market Size, Trends & Analysis - Forecasts to 2026 By Delivery System (Continuous Flow, and Pulse Flow), By Portability (Stationary Concentrator, and Mobile Concentrator), By Application (Cystic Fibrosis, Pneumonia, Asthma, Sleep Apnea, and Other Chronic Lung Diseases), End-User (Pediatric Specialty Hospitals, and Homecare Setting), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

The Global Pediatric Oxygen Concentrator Market is projected to grow at a CAGR value of around 12.0% during the forecast period [2021 to 2026]. Oxygen concentrators work by drawing air from the surrounding which has around 21% oxygen, around 78% of nitrogen, and 1% of other gases. It then separates and extracts NO2 from the mixture to offer almost pure oxygen i.e. around 90-95% oxygen. Read More »


July 21 : 2021

Global Enteral and Parenteral Nutrition Pumps Market Size, Trends & Analysis - Forecasts to 2026 By Feeding Type (Enteral [GI Track Feeding], Parenteral [Intravenous Feeding]), By Application (Ambulatory, Continuous, and Others), By Age (Adult and Pediatric), By Usage (Oncology, Neurology, Gastroenterology, Diabetes, Hypermetabolism, and Others), By End-User (Healthcare Settings, Homecare Settings, and Ambulatory Care Settings), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

The global enteral and parenteral nutrition pumps market is projected to grow at a CAGR value of 7.0% during the forecast period [2021 to 2026]. The enteral nutrition pumps are used to feed patients with food and liquid items through the gastrointestinal [GI] tract while the goal of parenteral nutrition pumps is to feed the patient through an intravenous route when the GI tract is not usable. Read More »


July 20 : 2021

Global Rheumatoid Arthritis Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Product (Biologics, Non-Biologics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Synthetic Disease-Modifying Antirheumatic Drugs, Other), Sales Channel (Prescription, OTC), By Route of Administration (Oral, Parenteral), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global rheumatoid arthritis therapeutics market is estimated to be valued at USD 25.66 billion in 2021 and is projected to reach USD 32.44 billion by 2026 at a CAGR of 4.8%. The key drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, growing joint deformities, soaring need for advanced treatment solutions, growing inflammatory diseases, increasing emergence of biologics, a growing proportion of individuals suffering from autoimmune disorders, mounting demand & desire for novel therapeutics, continually evolving medical facilities, growing geriatric population, increasing technological advancements, expanding government initiatives, rising legal governance alignment, and increasing research and development. Read More »


July 16 : 2021

Global Local Anesthesia Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global local anesthesia drugs market is estimated to be valued at USD 5.60 billion in 2021 and is projected to reach USD 6.75 billion by 2026 at a CAGR of 3.8%. The core drivers which contribute to the market expansion include the increasing volume of surgeries related to chronic diseases, cardiovascular, accidents, cancer, nervous disorders and even getting relief from post-surgery. Read More »


July 15 : 2021